Hypospadias and Exome: Identification of New Genes for Familial Hypospadias
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Jul 10, 2015
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
The aim of this protocol is to search for new genes involved in genital malformations such as hypospadias. Addressed to families with usual causes of these malformations excluded. The search for these mutations will be done by exome sequencing in families where several cases of hypospadias were identified.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hypospadiac patients with a familial history of hypospadias
- Exclusion Criteria:
- • Hypospadiac patients without a family history of hypospadias
- • Hypospadiac patients with a family history of hypospadias where etiology is identified
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier Cedex 5, , France
Patients applied
Trial Officials
Nicolas Kalfa, MD, PhD
Principal Investigator
UH Montpellier
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials